We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Synbiotics in Infants With Cyanotic Congenital Heart Disease

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01810978
First Posted: March 14, 2013
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Dilek Dilli, Dr. Sami Ulus Children's Hospital
  Purpose
Infants with congenital heart disease have more frequent infections and exposures to antibiotics than healthy infants. The investigators hypothesized that synbiotics may reduce the rate of sepsis and necrotizing enterocolitis in infants with CHD

Condition Intervention
Congenital Heart Disease Dietary Supplement: Bifidobacterium lactis plus inulin Dietary Supplement: Maltodextrin

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Efficacy of Synbiotics in Infants With Cyanotic Congenital Heart Disease

Resource links provided by NLM:


Further study details as provided by Dilek Dilli, Dr. Sami Ulus Children's Hospital:

Primary Outcome Measures:
  • Sepsis [ Time Frame: 8 weeks ]

Secondary Outcome Measures:
  • Necrotizing enterocolitis [ Time Frame: 8 weeks ]

Estimated Enrollment: 100
Study Start Date: October 2012
Study Completion Date: May 2013
Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Bifidobacterium lactis plus inulin
Bifidobacterium lactis plus inulin
Dietary Supplement: Maltodextrin
same amount of maltodextrin per day will be given as placebo
Placebo Comparator: maltodextrin
maltodextrin
Dietary Supplement: Bifidobacterium lactis plus inulin
5 billion unit Bifidobacterium lactis plus 900 mg inulin per day will be given

Detailed Description:
Infants with congenital heart disease have more frequent infections and exposures to antibiotics than healthy infants. Probiotics may prevent pathogen colonization in infants with CHD. Therefore, the investigators hypothesized that synbiotics may reduce the rate of sepsis and necrotizing enterocolitis in infants with CHD
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 3 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Cyanotic congenital heart disease
  • infants >35 weeks of gestational age
  • Born at or transferred to Sami Ulus CH

Exclusion Criteria:

  • Congenital anomalies of the intestinal tract
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01810978


Locations
Turkey
Sami Ulus CH
Ankara, Turkey, 06120
Sponsors and Collaborators
Dr. Sami Ulus Children's Hospital
Investigators
Principal Investigator: Banu Aydın, MD MD
  More Information

Additional Information:
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Dilek Dilli, Assoc Prof, Dr. Sami Ulus Children's Hospital
ClinicalTrials.gov Identifier: NCT01810978     History of Changes
Other Study ID Numbers: 128/01.10.2012
First Submitted: March 12, 2013
First Posted: March 14, 2013
Last Update Posted: October 12, 2017
Last Verified: May 2013

Keywords provided by Dilek Dilli, Dr. Sami Ulus Children's Hospital:
congenital heart disease, probiotic, prebiotic

Additional relevant MeSH terms:
Heart Diseases
Heart Defects, Congenital
Cardiovascular Diseases
Cardiovascular Abnormalities
Congenital Abnormalities